Interindividual and interethnic differences in the demethylation and glucuronidation of codeine

British Journal of Clinical Pharmacology
Q Y YueJ Säwe

Abstract

1. The 8 h urinary excretion of codeine and seven of its metabolites was compared in 149 healthy Swedish Caucasians and 133 healthy Chinese following a single oral dose of 25 mg codeine phosphate. 2. The total 8 h urinary recovery of drug-related material was 74 +/- 24% in the Caucasians and 60 +/- 14% in the Chinese (P less than 0.001). The excretion of unchanged codeine was significantly higher in the Chinese (7.2%) compared with the Caucasians (4.3%, P less than 0.001). 3. The Caucasians excreted significantly greater proportions of codeine-6-glucuronide (C6G) (62%) than the Chinese (44%) (P less than 0.001). The frequency distribution of the log metabolic ratio (MR) for glucuronidation (codeine/C6G) was shifted towards higher values in the Chinese population. Males in both groups and Chinese smokers had significantly lower glucuronidation MRs than females and non-smokers in the respective populations (P less than 0.001). 4. The frequency distribution of the MR for O-demethylation (codeine/morphine (M) + M-3 and M-6-glucuronide (M3G and M6G) + normorphine (NM) was highly skewed in the Caucasians, suggestive of a bimodal distribution. There was a 160-fold interindividual variation in this MR. A unimodal distribution of the lo...Continue Reading

References

Dec 1, 1989·British Journal of Clinical Pharmacology·Q Y YueJ Säwe
Apr 9, 1988·Lancet·R OsborneM Slevin
Oct 15, 1988·Lancet·Z R ChenF Bochner
Mar 2, 1989·The New England Journal of Medicine·W Kalow
Jan 1, 1987·European Journal of Clinical Pharmacology·K W BockJ Bircher
Dec 1, 1986·British Journal of Clinical Pharmacology·J A CritchleyL F Prescott
Oct 1, 1985·Clinical Pharmacology and Therapeutics·E SteinerF Sjöqvist
Nov 1, 1972·Australian and New Zealand Journal of Medicine·W B Jackson
Nov 1, 1983·British Journal of Clinical Pharmacology·J O MinersD J Birkett
Jan 1, 1980·Therapeutic Drug Monitoring·F SjöqvistM Asberg
Aug 1, 1982·Clinical Pharmacology and Therapeutics·J F RogersR M Welch
Jul 1, 1980·British Journal of Clinical Pharmacology·J C MucklowC T Dollery

❮ Previous
Next ❯

Citations

Mar 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P L JansenK W Bock
Jul 1, 1997·European Journal of Drug Metabolism and Pharmacokinetics·G M PacificiL Giuliani
Apr 10, 2009·European Journal of Clinical Pharmacology·Stacy S ShordRobert E Molokie
May 1, 1994·Clinica Chimica Acta; International Journal of Clinical Chemistry·A M BattG Siest
Jan 1, 1990·Pharmacology & Therapeutics·L BertilssonJ Reviriego
Jan 1, 1991·Pharmacology & Therapeutics·J O Miners, P I Mackenzie
Mar 1, 1991·Trends in Pharmacological Sciences·W Kalow
Feb 24, 1995·Neuroscience Letters·C JolivaltG Siest
Nov 7, 2001·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·J L DorneA G Renwick
Dec 1, 1989·British Journal of Clinical Pharmacology·Q Y YueJ Säwe
Jan 1, 1995·British Journal of Clinical Pharmacology·Z LiuA Rane
Jun 1, 1992·Journal of Internal Medicine·G Alván
Jan 1, 1991·Fundamental & Clinical Pharmacology·G Alván
Apr 1, 1995·Risk Analysis : an Official Publication of the Society for Risk Analysis·F Y BoisL Zeise
Aug 1, 1990·Pharmacology & Toxicology·S Loft, H E Poulsen
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·H G XieC M Stein
Apr 16, 2011·Pharmacology·Wojciech Leppert
Jun 1, 1997·Environmental Health Perspectives·B Burchell, M W Coughtrie
Feb 4, 2003·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Brian Burchell
Jun 14, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Meaghan O'MalleyNithya Ramnath
Sep 3, 2004·Journal of Clinical Pharmacology·Kiman KimHartmut Derendorf
Sep 16, 2003·Journal of Clinical Pharmacology·Thorir D BjornssonCaroline Loew
Oct 23, 2004·Drug Metabolism and Pharmacokinetics·Shogo OzawaJun-Ichi Sawada
Jun 21, 2016·Journal of Hazardous Materials·María RicoYolanda Picó
Jun 15, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jessica M van der BolFloris A de Jong
Aug 1, 1996·Clinical Pharmacology and Therapeutics·C Y TsengJ D Huang
Sep 28, 2001·British Journal of Anaesthesia·D G WilliamsR F Howard
Mar 1, 1997·Toxicology and Industrial Health·D W Nebert, M J Carvan
Aug 1, 1992·Biopharmaceutics & Drug Disposition·T B Vree, C P Verwey-van Wissen
Jan 1, 1991·Journal of Gastroenterology and Hepatology·M J FettmanI C Roberts-Thomson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.